Prepared Statement of the Federal Trade Commission On Protecting Consumer Access To Generic Drugs: The Benefits Of A Leglislative Solution To Anticompetitive Patent Settlements In The Pharmaceutical Industry

Tags:

Before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee On Energy and Commerce, United States House of Representatives

Date:
By: 
Jon Leibowitz, Former Chairman